Cited by 511Barrier Structure and Function StudiesCerebrospinal fluid and hydrocephalusDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

CSF, blood-brain barrier, and brain drug delivery

Pardridge, William M.·2016·Expert Opinion on Drug Delivery

DOI 10.1517/17425247.2016.1171315

Open this paper in CoChat — free account

Abstract

INTRODUCTION: There are 2 misconceptions about the cerebrospinal fluid (CSF), the blood-brain barrier (BBB), and brain drug delivery, which date back to the discovery of a barrier between blood and brain over 100 years ago. Misconception 1 is that drug distribution into CSF is a measure of BBB transport. Misconception 2 is that drug injected into the CSF compartment distributes to the inner parenchyma of brain. AREAS COVERED: Drug distribution into the CSF is a function of drug transport across the choroid plexus, which forms the blood-CSF barrier, and not drug transport across the BBB, which is situated at the microvascular endothelium of brain. Drug injected into CSF undergoes rapid efflux to the blood compartment via bulk flow. Drug penetration into brain parenchyma from the CSF is limited by diffusion and drug concentrations in brain decrease exponentially relative to the CSF concentration. EXPERT OPINION: The barrier between blood and brain was discovered in 1913, when it was believed that the BBB was localized to the choroid plexus, and that nutrient flow from blood passed through the CSF en route to brain. These misconceptions are still widely held, and hinder progress in the development of technology for BBB drug delivery.

Integrity signals

Registry

Crossref · 10.1517/17425247.2016.1171315

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

null
null (2016) · Philosophy Study · doi:10.17265/2159-5313/2016.09.003 · Cited by 28,317
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,776
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,457
The Permeability of Capillaries in Various Organs as Determined by Use of the ‘Indicator Diffusion’ Method
Crone, C. (1963) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1963.tb02652.x · Cited by 1,157
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
Evidence for a ‘Paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space
Rennels, M. L., Gregory, T. F., Blaumanis, O. R., Fujimoto, K., & Grady, P. A. (1985) · Brain Research · doi:10.1016/0006-8993(85)91383-6 · Cited by 752
Principles of neural science
de Jong, J. M. B. V. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90083-3 · Cited by 666
Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.
Pardridge, W. M., Boado, R. J., & Farrell, C. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38267-x · Cited by 606
Self-citation
Radioimmunotherapy of human tumours
Larson, S. M., Carrasquillo, J. A., Cheung, N. V., & Press, O. W. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3925 · Cited by 540

Show all 88 references

Research works printed but not linked: 11

Verrees M, 2004, Am Fam Physician, 70, 1071
Poplack DG, 1977, Cancer Res, 37, 1982
Brightman MW, 1993, The blood-brain barrier, 107
Anderson JM, 2001, News Physiol Sci, 16, 126
Reiber H, 2003, Restor Neurol Neurosci, 21, 79
Pardridge WM, 1985, Am J Physiol, 249, E534
Covell DG, 1985, Am J Physiol, 248, R147
10.17265/2159-5313/2016.09.003 · DOI · Paper page
Morrison PF, 1994, Am J Physiol, 266, R292
Cserr HF, 1981, Am J Physiol, 240, F319
Zhang X, 1998, Neurosci, 4, 1225

Sorted by citations

Items 101–200 of 511

Antibody transcytosis across brain endothelial-like cells occurs nonspecifically and independent of FcRn
Ruano-Salguero, J. S., & Lee, K. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-60438-z · Cited by 63
Nanotransducers for wireless neuromodulation
Li, X., Xiong, H., Rommelfanger, N. J., Xu, X., Youn, J., Slesinger, P. A., Hong, G., & Qin, Z. (2021) · Matter · doi:10.1016/j.matt.2021.02.012 · Cited by 61
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
Sharma, P., & Otto, M. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.08.022 · Cited by 59
Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients
Monteiro, C., SILVA, A. C. F. D., Ferreira, N., Mesgarzadeh, J. S., Novais, M., Coelho, T., & Kelly, J. W. (2018) · Amyloid · doi:10.1080/13506129.2018.1479249 · Cited by 58
Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release
Peviani, M., Palmiero, U. C., Cecere, F., Milazzo, R., Moscatelli, D., & Biffi, A. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.012 · Cited by 59
Structure of the Blood Brain Barrier and its Role in the Transporters for the Movement of Substrates across the Barriers
Ankul Singh, S., & Vellapandian, C. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230608110349 · Cited by 60
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Liao, J., He, W., Li, L., Wang, J., Gong, L., Zhang, Q., & Lin, Z. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100016 · Cited by 63
Re-engineering therapeutic antibodies for Alzheimer’s disease as blood-brain barrier penetrating bi-specific antibodies
Pardridge, W. M. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1230195 · Cited by 55
Self-citation
Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP/PS1 mice
Παπαδιά, Κ., Giannou, A. D., Markoutsa, E., Bigot, C., Vanhoute, G., Mourtas, S., der Linded, A. V., Stathopoulos, G. T., & Antimisiaris, S. G. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.03.010 · Cited by 56
Progress in Target Drug Molecules for Alzheimer's Disease
Xie, J., Liang, R., Wang, Y., Huang, J., Cao, X., & Niu, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191203113745 · Cited by 57
Advances in designing of polymeric micelles for biomedical application in brain related diseases
Kaur, J., Gulati, M., Kapoor, B., Jha, N. K., Gupta, P. K., Gupta, G., Chellappan, D. K., Devkota, H. P., Prasher, P., Ansari, M. S., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109960 · Cited by 55
Cedrol suppresses glioblastoma progression by triggering DNA damage and blocking nuclear translocation of the androgen receptor
Chang, K., Huang, X., Chang, J. T., Huang, Y., Weng, J., & Tsai, N. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.09.007 · Cited by 55
Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy
van den Broek, S. L., Shalgunov, V., & Herth, M. M. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213125 · Cited by 57
Human brain clearance imaging: Pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood
van Osch, M. J. P., Wåhlin, A., Scheyhing, P., Mossige, I., Hirschler, L., Eklund, A., Mogensen, K., Gomolka, R. S., Radbruch, A., Qvarlander, S., et al. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5159 · Cited by 58
The great barrier belief: The blood–brain barrier and considerations for juvenile toxicity studies
Schmitt, G., Parrott, N. J., Prinssen, E. P. M., & Barrow, P. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.06.043 · Cited by 56
The Promises and Challenges of Erythropoietin for Treatment of Alzheimer’s Disease
Sun, J., Martin, J. M., Vanderpoel, V., & Sumbria, R. K. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08524-y · Cited by 56
Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions
Wetzels, S., Vanmierlo, T., Scheijen, J. L. J. M., van Horssen, J., Amor, S., Somers, V., Schalkwijk, C. G., Hendriks, J. J. A., & Wouters, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00855 · Cited by 51
The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier
Pardridge, W. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00398 · Cited by 52
Self-citation
The impact of ATP-binding cassette transporters in the diseased brain: Context matters
Baltira, C., Aronica, E., Elmquist, W. F., Langer, O., Löscher, W., Sarkaria, J. N., Wesseling, P., de Gooijer, M. C., & van Tellingen, O. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101609 · Cited by 54
Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques
Meseck, E. K., Guibinga, G.-H., Wang, S. H., McElroy, C., Hudry, E., & Mansfield, K. G. (2022) · Toxicologic Pathology · doi:10.1177/01926233221101309 · Cited by 50
Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection
Huang, L., Wan, J., Wu, Y., Tian, Y., Yao, Y., Yao, S., Ji, X., Wang, S., Su, Z., & Xu, H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119142 · Cited by 49
Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches
Pellerino, A., Brastianos, P. K., Rudà, R., & Soffietti, R. (2021) · Cancers · doi:10.3390/cancers13122888 · Cited by 48
Intravenous 2-hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial
Hastings, C. A., Liu, B., Hurst, B., Cox, G. F., & Hrynkow, S. H. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.10.004 · Cited by 47
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain
Pardridge, W. M. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.602236 · Cited by 46
Self-citation
Intrathecal Injection in a Rat Model: A Potential Route to Deliver Human Wharton’s Jelly-Derived Mesenchymal Stem Cells into the Brain
Kim, H., Na, D. L., Lee, N. K., Kim, A. R., Lee, S., & Jang, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041272 · Cited by 47
Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer’s disease
Handa, M., Tiwari, S., Yadav, A. K., Almalki, W. H., Alghamdi, S. A., Alharbi, K. S., Shukla, R., & Beg, S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.020 · Cited by 44
Translational Approaches for Brain Delivery of Biologics via Cerebrospinal Fluid
Sadekar, S., Bowen, M., Cai, H., Jamalian, S., Rafidi, H., Shatz-Binder, W., Lafrance‐Vanasse, J., Chan, P., Meilandt, W. J., Oldendorp, A., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2531 · Cited by 44
Current Update on Transcellular Brain Drug Delivery
Pawar, B., Vasdev, N., Gupta, T., Mhatre, M., More, A., Anup, N., & Tekade, R. K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122719 · Cited by 50
Advances in the treatment of neuronal ceroid lipofuscinosis
Rosenberg, J. B., Chen, A., Kaminsky, S. M., Crystal, R. G., & Sondhi, D. (2019) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2019.1684258 · Cited by 41
Focused ultrasound as a novel strategy for Alzheimer disease therapeutics
Meng, Y., Volpini, M., Black, S. E., Lozano, A. M., Hynynen, K., & Lipsman, N. (2017) · Annals of Neurology · doi:10.1002/ana.24933 · Cited by 45
Safety of Direct Intraparenchymal AAVrh.10-Mediated Central Nervous System Gene Therapy for Metachromatic Leukodystrophy
Rosenberg, J. B., Chen, A., De, B. P., Dyke, J. P., Ballon, D. J., Monette, S., Ricart Arbona, R. J., Kaminsky, S. M., Crystal, R. G., & Sondhi, D. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.269 · Cited by 41
Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
Jin, Z., Han, Y., Zhang, D., Li, Z., Jing, Y., Hu, B., & Sun, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102070 · Cited by 45
Bioorthogonal chemical labeling of endogenous neurotransmitter receptors in living mouse brains
Nonaka, H., Sakamoto, S., Shiraiwa, K., Ishikawa, M., Tamura, T., Okuno, K., Kondo, T., Kiyonaka, S., Susaki, E. A., Shimizu, C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2313887121 · Cited by 41
Wernicke’s encephalopathy — from basic science to clinical practice. Part 1: Understanding the role of thiamine
Ott, M., & Werneke, U. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320978106 · Cited by 42
Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis
Chang, H.-Y., Wu, S., Li, Y., Zhang, W., Burrell, M. R., Webster, C. I., & Shah, D. K. (2021) · mAbs · doi:10.1080/19420862.2021.1874121 · Cited by 42
Blood and cerebrospinal fluid flow oscillations measured with real-time phase-contrast MRI: breathing mode matters
Laganà, M. M., Tella, S. D., Ferrari, F., Pelizzari, L., Cazzoli, M., Alperin, N. J., Jin, N., Zacà, D., Baselli, G., & Baglio, F. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00394-0 · Cited by 41
Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective
Puranik, N., Yadav, D., & Song, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814044 · Cited by 45
An Implantable Micro-Caged Device for Direct Local Delivery of Agents
Son, A. I., Opfermann, J. D., McCue, C., Ziobro, J. M., Abrahams, J. H., Jones, K., Morton, P. D., Ishii, S., Oluigbo, C. O., Krieger, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17912-y · Cited by 43
Neuroprotective effect of magnesium supplementation on cerebral ischemic diseases
Xu, R., Wang, L., Sun, L., & Dong, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119257 · Cited by 41
High-throughput glycolytic inhibitor discovery targeting glioblastoma by graphite dots–assisted LDI mass spectrometry
Shi, R., Pan, P., Lv, R., Ma, C., Wu, E., Guo, R., Zhao, Z., Song, H., Zhou, J. Z., Liu, Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl4923 · Cited by 41
Multifunctional LUV Liposomes Decorated for BBB and Amyloid Targeting. A. In Vitro Proof-of-Concept
Papadia, K., Markoutsa, E., Mourtas, S., Giannou, A. D., La Ferla, B., Nicotra, F., Salmona, M., Klepetsanis, P., Stathopoulos, G. T., & Antimisiaris, S. G. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.02.019 · Cited by 40
Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects
Pineda, E., Doménech, M., Hernández, A., Comas, S., & Balañá, C. (2023) · OncoTargets and Therapy · doi:10.2147/ott.s366371 · Cited by 44
Protein corona on brain targeted nanocarriers: Challenges and prospects
Jiang, K., Yu, Y., Qiu, W., Tian, K., Guo, Z., Qian, J., Lu, H., & Zhan, C. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115114 · Cited by 41
Low-Intensity MR-Guided Focused Ultrasound Mediated Disruption of the Blood-Brain Barrier for Intracranial Metastatic Diseases
Meng, Y., Suppiah, S., Surendrakumar, S., Bigioni, L., & Lipsman, N. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00338 · Cited by 39
Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice
Shiwaku, H., Katayama, S., Kondo, K., Nakano, Y., Tanaka, H., Yoshioka, Y., Fujita, K., Tamaki, H., Takebayashi, H., Terasaki, O., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100597 · Cited by 38
CSF circulation and dispersion yield rapid clearance from intracranial compartments
Hornkjøl, M., Valnes, L. M., Ringstad, G. A., Rognes, M. E., Eide, P. K., Mardal, K., & Vinje, V. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.932469 · Cited by 41
Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System
Spencer, A. P., Torrado, M., Custódio, B., Silva-Reis, S. C., Santos, S. D., Leiro, V., & Pêgo, A. P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020192 · Cited by 40
Efficiency of lipid-based nano drug delivery systems in crossing the blood–brain barrier: A review
Khaledian, S., Dayani, M., Fatahian, A., Fatahian, R., & R., F. M. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.118278 · Cited by 38
Reduction in Brain Heparan Sulfate with Systemic Administration of an IgG Trojan Horse–Sulfamidase Fusion Protein in the Mucopolysaccharidosis Type IIIA Mouse
Boado, R. J., Lu, J. Z., Hui, E. K., & Pardridge, W. M. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00958 · Cited by 38
Self-citation
Special delEVery: Extracellular Vesicles as Promising Delivery Platform to the Brain
Pauwels, M. J., Vandendriessche, C., & Vandenbroucke, R. E. (2021) · Biomedicines · doi:10.3390/biomedicines9111734 · Cited by 38
Drug delivery strategies to cross the blood-brain barrier in Alzheimer’s disease: a comprehensive review on three promising strategies
de Koning, L. A., Vazquez-Matias, D. A., Beaino, W., Vugts, D. J., van Dongen, G. A. M. S., van der Flier, W. M., Ries, M. G., van Vuurden, D. G., Vijverberg, E. G. B., & van de Giessen, E. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100204 · Cited by 41
Temporal analysis of blood–brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke
Zhang, Y., Fan, F., Zeng, G., Zhou, L., Zhang, Y., Zhang, J., He, J., Zhang, T., Su, D., Yang, C., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16680221 · Cited by 36
A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis
Eisen, A., Greenberg, B., Bowen, J., Arnold, D., & Caggiano, A. (2017) · Multiple Sclerosis Journal - Experimental, Translational and Clinical · doi:10.1177/2055217317743097 · Cited by 33
Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins
Pardridge, W. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114234 · Cited by 40
Self-citation
Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics
Ronaldson, P. T., & Davis, T. P. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2306138 · Cited by 41
Engineering EVs‐Mediated mRNA Delivery Regulates Microglia Function and Alleviates Depressive‐Like Behaviors
Ge, K., Bai, Z., Wang, J., Li, Z., Gao, F., Liu, S., Zhang, L., Gao, F., & Xie, C. (2025) · Advanced Materials · doi:10.1002/adma.202418872 · Cited by 36
Glucose, Fructose, and Urate Transporters in the Choroid Plexus Epithelium
Chiba, Y., Murakami, R., Matsumoto, K., Wakamatsu, K., Nonaka, W., Uemura, N., Yanase, K., Kamada, M., & Ueno, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197230 · Cited by 34
MiR-211 determines brain metastasis specificity through SOX11/NGN2 axis in triple-negative breast cancer
Pan, J.-K., Lin, C., Kuo, Y., Ger, L.-P., Cheng, H.-C., Yao, Y.-C., Hsiao, M., & Lu, P. (2021) · Oncogene · doi:10.1038/s41388-021-01654-3 · Cited by 36
Facilitating drug delivery in the central nervous system by opening the blood-cerebrospinal fluid barrier with a single low energy shockwave pulse
Kung, Y., Chen, K., Liao, W., Hsu, Y.-H., Wu, C., Hsiao, M., Huang, A. P., & Chen, W. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00303-x · Cited by 36
Isatin derived novel Schiff bases: An efficient pharmacophore for versatile biological applications
Pradeep, S. D., Gopalakrishnan, A. K., Manoharan, D. K., Soumya, R. S., Gopalan, R. K., & Mohanan, P. V. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.134121 · Cited by 36
A selective NaV1.1 activator with potential for treatment of Dravet syndrome epilepsy
Chow, C. Y., Chin, Y. K. ‐., Ma, L., Undheim, E. A. B., Herzig, V., & King, G. F. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113991 · Cited by 36
Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor
Pardridge, W. M., & Chou, T. (2021) · Pharmaceuticals · doi:10.3390/ph14060535 · Cited by 35
Self-citation
Inhibiting with-no-lysine kinases enhances K+/Cl− cotransporter 2 activity and limits status epilepticus
Lee, K. L., Abiraman, K., Lucaj, C., Ollerhead, T. A., Brandon, N. J., Deeb, T. Z., Maguire, J. L., & Moss, S. J. (2021) · Brain · doi:10.1093/brain/awab343 · Cited by 36
Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System
Semyachkina-Glushkovskaya, O. V., Shirokov, A. A., Андреевна, Б. И., Telnova, V., Vodovozova, E. L., Alekseeva, A. S., Boldyrev, I. A., Fedosov, I. V., Dubrovsky, A. I., Khorovodov, A., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010036 · Cited by 35
Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery
Kagiava, A., Richter, J., Tryfonos, C., Leal-Julià, M., Sargiannidou, I., Christodoulou, C., Bosch, A., & Kleopa, K. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-02694-1 · Cited by 34
BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors
Talloa, D., Triarico, S., Agresti, P., Mastrangelo, S., Attinà, G., Romano, A., Maurizi, P., & Ruggiero, A. (2022) · Cancers · doi:10.3390/cancers14174264 · Cited by 34
Estrogen Receptors Are Involved in the Neuroprotective Effect of Silibinin in Aβ1–42-Treated Rats
Song, X., Liu, B., Cui, L., Zhou, B., Liu, L., Liu, W., Yao, G., Xia, M., Hayashi, T., Hattori, S., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2481-3 · Cited by 34
Probing the brain with molecular fMRI
Ghosh, S., Harvey, P., Simon, J. C., & Jasanoff, A. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.03.009 · Cited by 33
Addition of Neostigmine and Atropine to Conventional Management of Postdural Puncture Headache: A Randomized Controlled Trial
Mahmoud, A. A. A., Mansour, A. Z., Yassin, H. M., Hussein, H. A., Kamal, A., Elayashy, M., Elemady, M. F. M., Elkady, H. W., Mahmoud, H. E., Cusack, B., et al. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003734 · Cited by 35
Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection
Tao, X., Mao, S., Zhang, Q., Yu, H., Li, Y., He, X., Yang, S., Zhang, Z., Yi, Z., Song, Y., et al. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03584-1 · Cited by 33
Intrathecal delivery and its applications in leptomeningeal disease
Khang, M., Bindra, R. S., & Saltzman, W. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114338 · Cited by 33
Stimuli-responsive nanoparticles delivered by a nasal-brain pathway alleviate depression-like behavior through extensively scavenging ROS
Liu, L., Liu, M., Xiu, J., Zhang, B., Hu, H., Qiao, M., Chen, D., Zhang, J., & Zhao, X. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.038 · Cited by 33
Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy
Wang, J., Liu, Y., Liu, F., Gan, S., Roy, S., Hasan, I., Zhang, B., & Guo, B. (2023) · Nanoscale · doi:10.1039/d3nr01667f · Cited by 33
Effective improvement of the neuroprotective activity after spinal cord injury by synergistic effect of glucocorticoid with biodegradable amphipathic nanomicelles
Wang, Y., Wu, M. C., Gu, L., Li, X., He, J., Zhou, L., Tong, A., Shi, J., Zhu, H., Xu, J., et al. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1256003 · Cited by 32
Selective drug delivery approaches to lesioned brain through blood brain barrier disruption
Al-Ahmady, Z. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1444601 · Cited by 29
Current state of immune checkpoints therapy for glioblastoma
Wang, H., Yang, J., Li, X., & Hai, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24729 · Cited by 36
LC–MS/MS analysis of twelve neurotransmitters and amino acids in mouse cerebrospinal fluid
Blanco, M. E., Barca‐Mayo, O., Bandiera, T., Tonelli, D. D. P., & Armirotti, A. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108760 · Cited by 35
Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice
Castellanos, D. M., Sun, J., Yang, J., Ou, W., Zambon, A. C., Pardridge, W. M., & Sumbria, R. K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090852 · Cited by 32
Self-citation
Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios
Sato, S., Matsumiya, K., Tohyama, K., & Kosugi, Y. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00609-6 · Cited by 31
Photomodulation of lymphatic delivery of liposomes to the brain bypassing the blood‐brain barrier: new perspectives for glioma therapy
Semyachkina-Glushkovskaya, O. V., Fedosov, I. V., Shirokov, A. A., Vodovozova, E. L., Alekseeva, A. S., Khorovodov, A., Андреевна, Б. И., Terskov, A. V., Тофик-Кызы, М. А., Klimova, M., et al. (2021) · Nanophotonics · doi:10.1515/nanoph-2021-0212 · Cited by 31
Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury
Li, J., Deng, J., Yuan, J., Fu, J., Li, X., Tong, A., Wang, Y., Chen, Y., & Guo, G. F. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s128705 · Cited by 31
Brain-Targeted Delivery of Pre-miR-29b Using Lactoferrin-Stearic Acid-Modified-Chitosan/Polyethyleneimine Polyplexes
Pereira, P., Barreira, M., Cruz, C., Tomás, J., Luís, Â., Pedro, A. Q., Queiroz, J. A., & de Sousa, F. P. (2020) · Pharmaceuticals · doi:10.3390/ph13100314 · Cited by 30
In vitro and in vivo models of BBB to evaluate brain targeting drug delivery
Sharma, B., Luhach, K., & Kulkarni, G. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00004-4 · Cited by 29
Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders
Bicker, J., Fortuna, A. C., Alves, G., & Falcão, A. C. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200115101544 · Cited by 30
Intrathecal delivery of Macromolecules: Clinical status and emerging technologies
Ajeeb, R., & Clegg, J. R. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114949 · Cited by 31
Prodrug strategy for enhanced therapy of central nervous system disease
Xia, X., Zhou, Y., & Gao, H. (2021) · Chemical Communications · doi:10.1039/d1cc02940a · Cited by 28
Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
Sonoda, H., Takahashi, K. P., Minami, K., Hirato, T., Yamamoto, T., So, S., Tanizawa, K., Schmidt, M., & Sato, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061240 · Cited by 33
Non-Invasive Techniques of Nose to Brain Delivery Using Nanoparticulate Carriers: Hopes and Hurdles
Butola, M., & Nainwal, N. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02946-z · Cited by 35
Choroid Plexus and Drug Removal Mechanisms
Sun, A., & Wang, J. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00587-9 · Cited by 29
Sustainable green synthesized nanoparticles for neurodegenerative diseases diagnosis and treatment
Thukral, P., Chowdhury, R., Sable, H., Kaushik, A. K., & Chaudhary, V. (2022) · Materials Today Proceedings · doi:10.1016/j.matpr.2022.10.315 · Cited by 28
The Blood-Brain Barrier and the EphR/Ephrin System: Perspectives on a Link Between Neurovascular and Neuropsychiatric Disorders
Malik, V. A., & Benedetto, B. D. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00127 · Cited by 31
Circadian Rhythms of the Blood-Brain Barrier and Drug Delivery
Kim, M., Keep, R. F., & Zhang, S. (2024) · Circulation Research · doi:10.1161/circresaha.123.323521 · Cited by 27
Toward Higher Sensitivity in Quantitative MALDI Imaging Mass Spectrometry of CNS Drugs Using a Nonpolar Matrix
Rzagalinski, I., Kovačević, B., Hainz, N., Meier, C., Tschernig, T., & Volmer, D. A. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02740 · Cited by 27
(Pyrrolo-pyridin-5-yl)benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons
Tzvetkov, N. T., Stammler, H., Hristova, S., Atanasov, A. G., & Antonov, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.009 · Cited by 27
Alzheimer’s disease: future drug development and the blood-brain barrier
Pardridge, W. M. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1627325 · Cited by 27
Self-citation
Multifunctional Nanopolymers for Blood–Brain Barrier Delivery and Inhibition of Glioblastoma Growth through EGFR/EGFRvIII, c-Myc, and PD-1
Patil, R., Sun, T., Rashid, M. H., Israel, L. L., Ramesh, A., Davani, S., Black, K. L., Ljubimov, A. V., Holler, E., & Ljubimova, J. Y. (2021) · Nanomaterials · doi:10.3390/nano11112892 · Cited by 27
Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders
Davidson, B. L., Gao, G., Berry‐Kravis, E., Bradbury, A. M., Bönnemann, C. G., Buxbaum, J. D., Corcoran, G. R., Gray, S. J., Gray‐Edwards, H. L., Kleiman, R. J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.014 · Cited by 27
Combining donepezil and memantine via mannosylated PLGA nanoparticles for intranasal delivery: Characterization and preclinical studies
Handa, M., Sanap, S. N., Bhatta, R. S., Patil, G. P., Ghose, S., Singh, D. P., & Shukla, R. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213663 · Cited by 29
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
Pellerino, A., Bertero, L., Rudà, R., & Soffietti, R. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418759618 · Cited by 27
Collision cross sections obtained with ion mobility mass spectrometry as new descriptor to predict blood-brain barrier permeation by drugs
Guntner, A. S., Thalhamer, B., Klampfl, C. W., & Buchberger, W. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-55856-7 · Cited by 26

Authors: Pardridge, W. M.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Pardridge, William M.
ORCID: Pardridge, William M.
Venue: Expert Opinion on Drug Delivery
Publisher: Informa UK Limited
Published: 2016-04-11
Volume: 13
Issue: 7
Pages: 963-975
ISSN: 1742-5247 (ISSN-L)
1744-7593
DOI: 10.1517/17425247.2016.1171315
OpenAlex: W2314371091
Cited by: 508
References: 88
Citations by year: 2026: 33 · 2025: 45 · 2024: 63 · 2023: 63 · 2022: 84 · 2021: 64 · 2020: 58 · 2019: 37 · 2018: 29 · 2017: 27 · 2016: 4
FWCI: 2.83
Type: journal article
Language: en
Open access: closed
Locations: Expert Opinion on Drug Delivery (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: cerebrospinal fluid, blood-brain barrier, brain drug delivery, choroid plexus, blood-CSF barrier, drug transport, bulk flow
MeSH terms: Animals, Biological Transport, Blood-Brain Barrier, Brain, Choroid Plexus, Humans, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CSF, blood-brain barrier, and brain drug delivery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks